AIS shopCareersSign In or register

References

  1. Hemilä, H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J 2011; 5: 51-8.
  2. Prasad, A. S. (2008). Zinc in human health: effect of zinc on immune cells. Molecular medicine, 14(5), 353-357.
  3. Walker, C. F., & Black, R. E. (2004). Zinc and the risk for infectious disease. Annu. Rev. Nutr., 24, 255-275.
  4. Hoffman HN, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterology 1988; 94: 508-12.
  5. Prasad, A. S., Beck, F. W. J., Bao, B., Snell, D., & Fitzgerald, J. T. (2008). Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. J Infect Dis, 197(6), 795-802.
  6. Johnstone, J., Roth, D. E., Guyatt, G., & Loeb, M. (2012). Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ, 184(10), E551-E561.
  7. Hemilä, H. (2017). Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM open, 8(5), 2054270417694291.
  8. Singh, M., & Das, R. R. (2013). Zinc for the common cold. Cochrane Database of Systematic Reviews, (6)

Back to top